Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

ASO Author Reflections: Potential of Peripheral Plasma Exosomal miRNA: miR-6855-5p Could Predict Radiosensitivity in Patients with Pancreatic Cancer, and Enhances Radioresistance.

Author information

Affiliations

  • 1. Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
      Authors
    • Ueda H 1
    • Takahashi H 1
    • Kobayashi S 1
    • Tomimaru Y 1
    • Sasaki K 1
    • Iwagami Y 1
    • Yamada D 1
    • Asaoka T 1
    • Noda T 1
    • Shimizu J 1
    • Doki Y 1
    • Eguchi H 1
    (12 authors)
  • 2. Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
      Authors
    • Kubo M 2
    (1 author)

ORCIDs linked to this article

Annals of Surgical Oncology, 19 Sep 2024,
https://doi.org/10.1245/s10434-024-16235-3 PMID: 39299990 

Abstract 

The efficacy of preoperative treatment for pancreatic cancer (PC) has been reported in randomized controlled trials, but the optimal regimen and the appropriateness of combining radiotherapy remain controversial. Therefore, predicting the efficacy of preoperative treatment using biomarkers and determining whether to combine chemotherapy or radiotherapy based on the biology of individual tumors could help personalize treatment and maximize therapeutic outcomes. In this study, a microRNA (miRNA) microarray analysis was performed using peripheral blood plasma exosomes from 10 PC patients who underwent neoadjuvant chemoradiotherapy, leading to the identification of miR-6855-5p as a candidate miRNA. miR-6855-5p was found to induce radioresistance in PC cells. In another cohort of 28 patients, it was observed that those with higher expression levels of miR-6855-5p in peripheral blood plasma exosomes tended to have increased radioresistance (r = - 0.5964). In future, measuring plasma exosomal miR-6855-5p before treatment could potentially lead to precision medicine by personalizing the decision of whether to include radiotherapy in the treatment plan.

Full text links 

Read article at publisher's site: https://doi.org/10.1245/s10434-024-16235-3

References 

Articles referenced by this article (3)

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.